MedTrace Logo

European Society of Cutaneous Lupus Erythematosus (EUSCLE)

NCT00420121 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-02-08

No results posted yet for this study

Summary

Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical manifestations and a variable prognosis. The aim of the study is to create a standardized evaluation of the different subtypes of this disease in order to receive an overview of the spectrum of clinical and laboratory features as well as the therapeutic strategies for patients with CLE.

Conditions

  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Systemic

Interventions

PROCEDURE

laboratory analysis

blood withdrawal for laboratory analysis

Sponsors & Collaborators

  • European Society of Cutaneous Lupus Erythematosus e.V.

    lead OTHER

Principal Investigators

  • Annegret Kuhn, MD · University of Muenster, Department of Dermatology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2018-07-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420121 on ClinicalTrials.gov